New therapeutic approach by G2013 in experimental model of multiple sclerosis.
about
Hydroxycitric acid ameliorates inflammation and oxidative stress in mouse models of multiple sclerosis.The Role of M2000 as an Anti-inflammatory Agent in Toll-Like Receptor 2/microRNA-155 Pathway.Efficacy and Safety of G2013 as a Novel Immunosuppressive Agent on Differentiation, Maturation and Function of Human Dendritic Cells.Preclinical and pharmacotoxicology evaluation of α-l-guluronic acid (G2013) as a non-steroidal anti-inflammatory drug with immunomodulatory property.Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies.Therapeutic effects of pegylated-interferon-α2a in a mouse model of multiple sclerosis.
P2860
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
@en
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
@nl
type
label
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
@en
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
@nl
prefLabel
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
@en
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
@nl
P2860
P50
P1476
New therapeutic approach by G2013 in experimental model of multiple sclerosis
@en
P2093
Sanaz Afraei
Seyed Jalal Zargar
P2860
P2888
P304
P356
10.1007/S13760-014-0392-X
P577
2014-11-12T00:00:00Z